neurocare group AG announces MDMA approval of TMS Devices in Saudi Arabia
Patient Receives Depression Treatment Using neurocare’s Apollo TMS System Munich, Germany and Riyadh, Saudi Arabia – neurocare group AG (“neurocare” or the “Company”), a best practice platform for mental health and performance, is pleased to announce the Saudi Food & Drug Authority (SFDA) has granted the Company Medical Device Marketing Authorization (MDMA) approval to sell its […]